What is Qualtex?
Qualtex Laboratories, founded in 2007 and headquartered in San Antonio, Texas, is a specialized testing laboratory. The company offers a comprehensive suite of services including blood and plasma screening, reference testing, and clinical research for patients, donors, and regulated biological products. Its operations extend to testing facilities in Norcross, Georgia, and it functions as a subsidiary of BioBridge Global. Qualtex's core services encompass whole blood donor screening, source plasma donor screening, and HCT/P donor screening for human cells, tissues, eyes, organs, and cellular and tissue-based products. Additionally, it provides immunohematology reference laboratory services and specialty testing, such as potency assays, clinical research/trials, non-FDA licensed assays, and research and development.
How much funding has Qualtex raised?
Qualtex has raised a total of $850K across 2 funding rounds:
Debt
$350K
Debt
$500K
Debt (2020): $350K with participation from PPP
Debt (2021): $500K led by PPP
What's next for Qualtex?
The substantial enterprise-level funding and recent strategic investment indicate a strong growth phase for Qualtex Laboratories. This capital infusion is likely to fuel expansion of its testing capabilities, enhancement of its research and development initiatives, and potentially broaden its market reach within the critical biological products and patient services sector. The company's focus on essential screening and reference testing positions it for continued relevance and development in the healthcare and biotechnology landscape.
See full Qualtex company page
